Vantage Investment Advisors’s Eyegate Pharmaceuticals, Inc. Warrants EYEGW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q3 | – | Sell |
-2,500
| Closed | – | – | 824 |
|
|
2018
Q2 | $0 | Hold |
2,500
| – | – | ﹤0.01% | 847 |
|
|
2018
Q1 | $0 | Hold |
2,500
| – | – | ﹤0.01% | 888 |
|
|
2017
Q4 | $0 | Hold |
2,500
| – | – | ﹤0.01% | 870 |
|
|
2017
Q3 | $0 | Hold |
2,500
| – | – | ﹤0.01% | 837 |
|
|
2017
Q2 | $0 | Hold |
2,500
| – | – | ﹤0.01% | 812 |
|
|
2017
Q1 | $0 | Hold |
2,500
| – | – | ﹤0.01% | 825 |
|
|
2016
Q4 | $1K | Hold |
2,500
| – | – | ﹤0.01% | 772 |
|
|
2016
Q3 | $1K | Hold |
2,500
| – | – | ﹤0.01% | 757 |
|
|
2016
Q2 | $0 | Hold |
2,500
| – | – | ﹤0.01% | 915 |
|
|
2016
Q1 | $2K | Hold |
2,500
| – | – | ﹤0.01% | 728 |
|
|
2015
Q4 | $2K | Hold |
2,500
| – | – | ﹤0.01% | 716 |
|
|
2015
Q3 | $3K | Buy |
+2,500
| New | +$3K | ﹤0.01% | 685 |
|